Skip to main content
. 2017 May 9;8(44):78133–78143. doi: 10.18632/oncotarget.17726

Table 2. SNPs with the lowest P values associated with adverse events (AEs) in chemotherapy cycles 1, 2, and 3.

SNP Chr Position Closest gene(s) MAFAE yes MAFAE no Raw P value Corrected P value
rs12050587 15 55335330 PIGB 26.8 21.3 1.0 × 10–4 0.03
rs11636687 15 55312954 RAB27A | PIGB 20.5 15.6 1.2 × 10–4 0.03
rs9514827 13 108267055 ABHD13 | TNFSF13B 28.0 32.6 2.9 × 10–3 0.70
rs4261468 15 55263404 RAB27A 24.1 20.2 4.6 × 10–3 1.00
rs2290344 15 55327598 PIGB 13.1 10.2 6.4 × 10–3 1.00
rs12050885 15 55266426 RAB27A 15.2 12.2 8.2 × 10–3 1.00
rs8024695 15 55347107 PIGB 13.3 10.7 1.9 × 10–2 1.00
rs4896870 6 146506145 GRM1 | RAB32 11.7 9.3 2.6 × 10–2 1.00
rs2595500 11 6941934 ZNF215 19.1 22.1 3.6 × 10–2 1.00
rs2607659 8 102227775 RRM2B 46.8 50.1 4.7 × 10–2 1.00

AE, adverse event; Chr, chromosome; MAF, minor allele frequency; SNP, single nucleotide polymorphism.

The table lists minor allele frequencies (MAFs) as well as raw and corrected P values resulting from comparison between the genetic and clinical logistic regression models (“Gene1 | Gene2” indicates the two genes between which the SNP is located).